COVID-19 Vaccination Disease (CVD): An Emerging Health Problem
There are thousands of diseases affecting humans, some are common globally and a few are locally confined. Most of the emerging diseases are zoonotic and have some known or unknown host in nature. Many of the diseases are associated with human invasion into the niche of other hosts prompting the disease agent to jump the host else that to vanish. However, several bio-weapons are known and used in the past to ruin opponents (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1326439/), all are of natural concern to their origin. The most advanced stage in Biowar may be the creation of novel weapons to counter all known means to counter biological agents either used in the past or have the potential to be used. The emergence of COVID-19 caused by SARS-CoV-2, supposedly created in the Wuhan lab with the help of the USA is a big mystery, no one yet knows whether it was created or naturally jumped from the heaven of pathogens (https://www.researchgate.net/publication/351071973_The_COVID19_A_Mystery_Disease). To counter the devastating, fast mutating, airborne SARSCoV-2 infections, for the first time genetically designed and genetically modified (GM) vaccines are used all over the globe as emergency experimental vaccines. Some scientists are skeptical of their purpose (https://www.bitchute.com/video/2MoJLG4VvNK2/?s=08; https://www.researchgate.net/publication/352933023_Why_sceptical_of_recommending_the_use_of_ COVID-19_vaccines_in_the_reproductive_age), their utility (https://www.researchgate.net/publication/348192258_Pros_and_Cons_of_Covid19_vaccines_and_vaccination_DOI1012032IDR2021B0207001) and their success (https://www.researchgate.net/publication/354372859_Impact_of_COVID19_Vaccination_on_COVID-19_Cases_and_Deaths). In the past, world leaders have not allowed even GM foods to be consumed but to save the lives of their people all permitted use of GM vaccines to be directly inoculated in the human body probably duress of pharmacopolitical pressure. The next will be the release of all GM food seeds under the plea, “If GM vaccines can be used why not GM foods”. Though all vaccines are associated with one or another problem or reaction when a vaccine itself becomes a major cause of death or promotes the other pathogen to cause the disease (https://www.researchgate.net/publication/354372859_Impact_of_COVID19_Vaccination_on_COVID-19_Cases_and_Deaths) can be considered a disease-causing agent. The question is whether COVID-19 vaccines (CV) may be classified as a disease-causing agent precipitating the COVID-19 Vaccination Disease (CVD)?
Description of CVD
Causative agent: Many variants of the COVID-19 Vaccine (CV)
Characteristics of Causal agent: COVID-19 vaccines have the following major characteristics. (https://hillmd.substack.com/p/leaders-who-demand-you-and-your-children)
Encode the toxic viral spike protein, known to cause blood clotting, inflammation, and other adverse effects and which appears to be a bioweapon;
Narrowly focus only on the spike protein antigen, allowing easy escape by the virus from vaccinal immunity;
Vaccines are nonsterilizing (“leaky”), meaning they limit illness — at least at first — but don’t prevent viral infection or transmission;
They promote selection for more infectious, vaccinal antibody-escape viral variants, such as Delta, Mu, and Lambda, particularly rapidly when mass vaccination occurs during a pandemic, i.e., under high infectious pressure;
Erode natural, innate immunity to coronaviruses, especially in young, healthy people;
Fail to exclude potentially dangerous epitopes (amino acid sequence regions) in the spike protein that could provoke autoimmunity (see Vojdani and Kanduc) or antibody-dependent enhancement of coronavirus infections; and
Lack of long-term safety and efficacy data.
Spike proteins are the real weapon of all these vaccines and it is now proven that SARS–CoV–2 spike protein significantly inhibits DNA damage repair. the spike protein localizes in the nucleus and inhibits DNA damage repair by impeding key DNA repair protein BRCA1 and 53BP1 recruitment to the damaged site. Our findings reveal a potential molecular mechanism by which the spike protein might impede adaptive immunity and underscore the potential side effects of full-length spike-based vaccines (Ziang and Mei, 2021; https://www.mdpi.com/1999-4915/13/10/2056). The bigger picture of the failed DNA repair may be the emergence of cancers, lethal and mutilating mutations in the germ cells, i.e., total destruction of the human race.
Incubation period: 12-72 h Duration of Illness: Two to three days but maybe lifelong too.
Signs and symptoms of CVD: The most common are pain at the inoculation site, redness or swelling at the injection site, headache, fatigue, muscle pain, fever/chills, nausea, and swollen lymph nodes. However, many injected may go symptomless too. However, chances of experiencing any of these symptoms after getting CV differ according to the specific CV variant (https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccinessafety). If you are bitten by AstraZeneca or J&J variant of CV, you may have the life-threatening extensive risk of blood clots, known as thrombosis with thrombocytopenia syndrome (TTS), accompanied by shortness of breath, chest pain, leg swelling, persistent abdominal pain, 2 severe headaches or blurred vision, easy bruising or tiny blood spots under your skin even beyond the injection site. Moderna and Pfizer CV variants may cause myocarditis and pericarditis in people, especially in adolescents and young adults (https://share.upmc.com/2021/04/age-and-sex-covid-19-vaccine/). The risk of myocarditis was 18.5/ million inoculations in people aged 18 to 24 after their second Pfizer dose and 20.2/ million for the same age group among Moderna second inoculation recipients (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html) After Pfizer-BioNTech CV, 88.7% of people ages 18 to 55 experience local reactions, and 82.8% systemic reactions. In older (>55 yrs) people, 79.7% may have local reactions, and 70.6% face systemic reactions. After Moderna CV, patients between 18 to 59 years reported both local and systemic reactions at a higher rate after both doses than those >60 years. After Johnson & Johnson/Janssen (J&J) CV, 59.8% of 18 to 59-year-olds have local reactions and 61.5% systemic reactions. In >60 years old, 35.4% have local reactions and 45.3% reported systemic reactions. After AstraZeneca CoviShield CV infection, people in the age group of 20-29 yrs, 81% experienced one or other symptoms listed above, while only 7% of 80-90-year-olds experienced the symptomatic disorder. Interestingly, 74.7% of women and 58.6% of men experienced post-inoculation symptoms. The common symptoms include tiredness (45%), myalgia (44%), fever (34%), headache (28%), local pain at the injection site (27%), joint pain (12%), nausea (8%) and diarrhea (3%). (https://www.medrxiv.org/content/10.1101/2021.02.08.21251366v1). Fluctuating BP following COVID vaccination, a sign of autonomic neuropathy, is now very frequently reported and worrying millions of people.
Morbidity and Mortality: Once you have a CV, morbidity may be more than 30-80%, and mortality in the US is reported at 68.37 per million CV-infected people. However, morbidity and mortality are reported to vary in different parts of the world depending on the cost of human life and the influence of pharmacopolitics on the health system in diagnosis and reporting. Morbidity rates are minimal and mortality by CVD is nearly nil in India due to effective disease control policies adopted (https://azadazadindia.blogspot.com/2017/06/blog-post_30.html).
Among the seriously affected cases of CVD main syndromes reported are anaphylaxis occurring in about 5 people exposed to CV in the United States, thrombosis with thrombocytopenia syndrome (TTS) after Johnson & Johnson’s Janssen (J&J/Janssen) variants of CV occurring in about three of per million exposed, Guillain-Barré Syndrome (GBS, a rare disorder where the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis, some have permanent nerve damage) in 11/ million people exposed to J&J/Janssen CV, myocarditis and pericarditis reported in 1,377 people aged ≤30 yrs on exposure to Pfizer-BioNTech or Moderna variants of CV, particularly in male adolescents and young adults and death maybe there are >68 people per million of the exposed to CVs (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html). The most common side effects in the UK for all vaccines can occur at a rate of more than one per 10 doses (such as local reactions, and symptoms resembling transient flu-like symptoms).
Other important syndromes associated with COVID-19 vaccination (https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting): Based on UK Data where 49068705 doses of vaccines were used till 6th October 2021.
Death rates for AstraZeneca-CoviShield are 23.24 deaths/ million doses; for Moderna, it is 7.41/ million doses, and for 12.83/ million doses. And for other vaccines (not detailed it is very high i.e. 620/ million doses.
Blood clots with concurrent low platelets (CVST): Thorough review into UK reports of an extremely rare specific type of blood clot in the brain, known as cerebral venous sinus thrombosis (CVST) occurring together with low levels of platelets (thrombocytopenia) following vaccination with the COVID-19 Vaccine AstraZeneca. It has the following signs and symptoms:
- a severe headache that is not relieved with simple painkillers or is getting worse or feels worse when you lie down or bend over
- an unusual headache that may be accompanied by blurred vision, confusion, difficulty with speech, weakness, drowsiness, or seizures (fits)
- rash that looks like small bruises or bleeding under the skin beyond the injection site
- shortness of breath, chest pain, leg swelling, or persistent abdominal (tummy) pain.
Menstrual disorders (period problems) and unexpected vaginal bleeding: A total of 40,256 suspected reactions relating to a variety of menstrual disorders have been reported after all three of the COVID-19 vaccines including heavier than usual periods, delayed periods, and unexpected vaginal bleeding.
Myocarditis and Pericarditis: Myocarditis and Pericarditis are reported in people aged below 18 years after COVID-19 vaccination. Myocarditis (including viral myocarditis), after both the first and second dose, is 8 reports per million doses of Pfizer/BioNTech, and for pericarditis (including viral pericarditis and infective pericarditis) the overall reporting rate is 6 reports per million doses.
Guillain-Barré Syndrome: MHRA has received 428 reports of Guillain-Barré Syndrome with the COVID-19 Vaccine AstraZeneca and 26 reports of a related disease called Miller Fisher syndrome. Up to the same date, the MHRA has received 55 reports of Guillain-Barre Syndrome following the use of the Pfizer/BioNTech vaccine and 1 report of Miller Fisher syndrome, and for the COVID-19 Vaccine Moderna, there have been three reports of Guillain-Barré Syndrome.
Mental problems & Nervous system disorders: Mood disorders, including depression, and schizophrenia spectrum disorders. As per FDA documents, in the 2 ½ months following Emergency use authorization (EUA), Pfizer received a total of 42,086 reports containing 158,893 “events.” Most of these reports were from the U.S. and disproportionately involved women (29,914 vs. 9,182 provided by men) and those between 31 and 50 years old (13,886 vs 21,325 for all other age groups combined, with another 6,876 whose ages were unknown). Also, 25,957 of the events were classified as “Nervous system disorders” (https://aaronsiri.substack.com/p/fda-produces-the-first-91-pages-of). In the said period (Till 28th February 2020) 56 million people received COVID-19 vaccines in the USA, 4.6 people of every 1000 vaxed.
Deaths: The MHRA has received 562 UK reports of suspected ADRs to the Pfizer/BioNTech vaccine in which the patient died shortly after vaccination, 1,106 reports for the COVID-19 Vaccine AstraZeneca, 20 for the COVID-19 Vaccine Moderna, and 31 where the brand of the vaccine was unspecified.
Prevention and Control: Neither available nor possible in near future.
Disease Analysis
If we consider that the data from CDC is truthful, then by 27th August 2021a total of 203475192 people in the USA got one or two shots of COVID-19 vaccines (mRNA) and as per records of Vaccine Adverse Event Reporting System (VAERS of CDC) till 27 August 2021 (Tab. 1), more than 13,900 people died because of COVID-19 vaccines (68.37 per million), 88.94 per million had a permanent disability, 278.87 per million were hospitalized for treatment, and 2 per million born with defects (Tab. 1) over the past eight months. By 27 August 2021, a total of 650,077 (3194.87 per million) had one or other vaccine-associated problems after COVID-19 vaccinations. However, it is noticeable that only 0.72% (1,466,266) of the vaccinated population registered on VAERS) and it can be assumed that this is not the total picture of the adverse effects of the COVID-19 vaccine. (https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=CAT&EVENTS=ON&VAX= COVID19). Another report by the CDC shows that since July 26, there have been only 6,587 reports of 3 breakthrough infections that resulted in hospitalization or death among 163 million fully vaccinated people i.e., 40.4 cases per million. (https://www.healthline.com/health-news/risks-of-the-deltavariant-for-vaccinated-vs-unvaccinated-people#A-more-contagious-variant) that means quite a good number of vaccine inefficacy cases are recorded.
The calculation for NSD: If 0.46% of people have Nervous system disorder (NSD) after the COVID-19 vaccination in just 2.5 months of EUA of mRNA vaccines, you may easily calculate that these vaccines can send 0.15 million US citizens who may have NSD after the Covid-19 vaccine jabs which are to be repeated two or three times a year. As per records (https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html), 7,655,073,020 doses of COvid-19 vaccines have been delivered till now so how many NSD cases maybe there by now globally? Just, 3.5398 million in less than a year, how many may be in the next few years? We may have a neurologically wracked world very soon.
Inference: What can be inferred from the COVID-19 data (https://www.worldometers.info/coronavirus/country/us/) and table above from VAERS? In Pre COVID-19 Vaccine time i.e., in 2020 in 12 months there were 365738 (~1100 per million population) deaths of the 20634571 (~62000 per million) COVID cases in the USA. After the introduction of the vaccine i.e., in 2021 in 8 months, COVID-19 deaths are 885 per million (maybe 1328 per million by the end of the year) and cases are 58610 per million (maybe 87915 per million by the end of the year). The impacts of vaccination on prevention/ control of COVID-19 are appreciable; it may be just a 21% increment to COVID-19 deaths and 42% to COVID-19 cases by the end of 2021 over 2020. Is it not the appreciable impact of COVID-19 vaccination? Besides, vaccines also added 3194.87 cases of adverse reactions and 68.37 deaths per million of vaccinations. Besides, we might have more than 3.5 million NSD cases i.e., a neurologically wracked world with madness & family disturbances rising, more problems, and a golden opportunity for big Neuro-medicine production for Greedy Pharmaceuticals.
Further Analysis
We may have the following assumptions:
1. The data provided by CDC and VAERS are 100% Correct (though the validity of their data is questioned several times, https://www.statnews.com/2021/05/11/cdc-messaging-covid19-seems-out-of-step-public-health-experts-say/; https://coronavirus.medium.com/the-latestcovid-19-testing-delays-reach-absurd-levels-4b9620f9ab85).
2. COVID-19 vaccines are disease-causing agents and cause CVD.
3. 100% of the population (333 million in the USA) has to be vaccinated at least twice a year be vaccinated.
Facts: As per the table
1. COVID-19 vaccines when inoculated to a million people it causes one or more complications in 3194.87, death of 68.37, permanent disability among 88.94, 374.02 emergency visits to the doctor, 278.87 hospitalizations, 0.83 prolonged hospitalizations, 1.99 birth defects, 70.41 life-threatening complications, and 1347.66 cases of mild illness.
Calculations: Now calculate for 333 million US citizens if all got vaccinated twice in a year (as booster vaccination will be a must to be protected) i.e., 666 million vaccinations every year: There may be 2127784 cases of CVD, death of 45532, permanent disability among 59237, 249094 emergency visits to the doctor, 185727 hospitalizations, 533 prolonged hospitalizations, 1326 kids born with birth defects, 46894 life-threatening complications and 897540 cases of mild illness. Does it not appear to be an impressive portfolio of a disease? The top 12 causes of deaths in the USA as per CDC (https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm) in 2019 were heart disease (659,041), cancer (599,601), accidents or unintentional injuries (173,040), chronic lower respiratory diseases (156,979), stroke or cerebrovascular diseases (150,005), Alzheimer’s disease (121,499), diabetes (87,647), nephritis, nephrotic syndrome, and nephrosis (51,565), influenza and pneumonia (49,783), intentional self-harm or suicide (47,511), septicemia (38,940) and chronic liver disease and cirrhosis (38,170). However, in 2020, COVID-19 was the 3rd leading cause of death in the USA with 365,738 deaths. Thus, what may be the place of CVD, probably the 11th or 12th leading cause of death in the USA?
Future/ predictions: Now imagine the whole world with a population of 7.9 billion to be vaccinated twice in a year i.e, 15.8 billion vaccinations a year, if vaccinated with the safest COVID-19 vaccines claimed by CDC (Pfizer and Moderna, used in the USA) what may be the scenario of CVD deaths, about 1.08 million deaths each year. But still behind COVID-19 the death toll of 1.9 million in 2020. Thus we can afford to have CVD instead of COVID-19. However, COVID-19 will settle as an endemic flu-like disorder in due course of time but to get rid of CVD you will need the permission of the WHO, CDC, and many more depending on the politics of different countries.
Indian perspective: By 15th October 2021India has inoculated 971163447 doses of COVID-19 Vaccine majority of which are of CoviShield, as per UK data estimates for AstraZeneca CoviShield about 22565 vaccine recipients might have already died due to Covid vaccine.
The future in India: India has a population of 1397.42 million as of
today, suppose the population remains static, we target to vaccinate 70% of our
population (though 100% should be as per new WHO suggestions), we need to
vaccinate twice in a year to get protection which means every year we have to use about
1956 million doses of COVID vaccine. So, ~28100 may be requiring intensive care
following anaphylaxis after Covid vaccination and ~45500 may die i.e., ~91000
in two years may die. Certainly, this figure is impressive as COVID has killed 452000
Indians in two years i.e., the vaccine can save about 80% of Indians who could have
died of COVID-19 (provided the vaccine is 100% protective). So COVID-19 vaccination is a game of profit, that must be played. In India, about 80000 people die of Tuberculosis every year (
Limitations and Confounders in the Analysis
1. Because VAERS is a passive reporting system, many adverse reactions to vaccines may not be reported (Kristine M. Severyn, Jacobson v. Massachusetts: Impact on Informed Consent and Vaccine Policy, 5 J. of Pharmacy and Law 249, 268, 1996). The CDC describes VAERS as a “passive reporting system.” Pre-dating the internet, the VAERS database has virtually no guards against its potential role as a source of “fake news” and is credulous of even the most fanciful claims of COVID-19 vaccine side effects. VAERS reports “can be submitted voluntarily by anyone, including healthcare providers, patients, or family members.”
2. Age of getting CV is an important determinant of having the adverse effects of COVID-19 vaccines (https://share.upmc.com/2021/04/age-and-sex-covid-19-vaccine/). The big difference in the average age of populations of different nations may lead to variation in outcome.
3. There are several variants of CV with extensive variations in their morbidity and mortality and their prevalence varies in different nations (https://www.gavi.org/vaccineswork/covid-19-vaccinerace). The calculations in the present analysis are based on two variants of CV in the USA; those are considered the mildest (safest) variants. Therefore, there may be a huge difference between predictions and reality.
4. All nations can’t afford the 100% infection of their population with CV due to several determinants including educational, political, geographical, social, economic, religious reasons, and many more, thus the outcome in different nations may be different as has been observed for COVID-19 (https://www.researchgate.net/publication/341271597_Changing_Relations_of_COVID19_Morbidity_Mortality_and_CFR_with_the_World; https://www.researchgate.net/publication/340887162_Epidemiological_Determinants_of_Acute_R espiratory_Syndrome_Coronavirus-2_Disease_Pandemic_and_The_Role_of_the_BacilleCalmette-Guerin_Vaccine_in_Reducing_Morbidity_and_Mortality; https://www.researchgate.net/publication/340443017_Are_BCG_Vaccination_Population_Density _Median_Age_and_Poverty_Important_Determinants_of_COVID19_Pandemic_Spread_Morbidity_and_Mortality).
5. The prevalence of CV is also variable in different countries at present (https://en.wikipedia.org/wiki/Deployment_of_COVID-19_vaccines), however, WHO is trying its 5 best to make it equitably 100% in all nations through The COVID-19 Vaccine Equity Project (https://www.sabin.org/programs/covid-19-vaccine-equity-project) and COVAX (https://www.who.int/initiatives/act-accelerator/covax).
6. Honesty in reporting disease occurrence and mortality due to death is a big issue all over the world (https://azad-azadindia.blogspot.com/2017/06/blog-post_30.html) and different nations have different policies for that thus the outcome of calculations is amenable to change.
7. Underreporting of CVD as an intentionally ignored syndrome is very much possible in almost all nations due to one or another reason thus CVD may go as an emerging neglected disease all over the world as several other diseases of poor people are going on (https://www.researchgate.net/publication/350485215_COVID_Mania_and_Truth_of_Life_ACTA _SCIENTIFIC_Pharmacology; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206025/).
8. Pharmacopolitical incentives for reporting as available for COVID-19 all over the world may be grossly lacking for CVD is another hurdle to getting recognition for this new and emerging disease and the disease may go intentionally unnoticed.
9. Even under duress of pharmacopolitical pressure all public leaders are not equally insensitive, authoritarian, and selfish, and several of them may not allow the CV to have blanket exposure to the masses in their country or some may even ban it in due course time, then the outcome of this predictive analysis may vary.
10. Moreover, the living system never goes by simple mathematics and statistics, every time it creates a new mathematical model that is too not to follow but to experiment. Susceptibility to CVD may vein out slowly or rapidly over the coming years as is the case for all other diseases (the difference is, the earlier diseases are natural in origin and follow the law of nature while CVD is 100% manmade and nobody knows either it will follow manmade rules or natural law) due to survival of the fittest (resistant to CVD).
11. As CVD is a fully man-made disease it is easily mutable and the outcome may vary with newer mutants of the causal agent (CV). It may also vanish abruptly or may blast abruptly; all is hidden in the womb of the future.
12. A study revealed that the two-dose exposure of the BNT162b2 CV is effective for a short period of 2 months and becomes totally ineffective in six months thus to have the disease continuously a five-monthly regime of re-inoculation is suggested (https://doi.org/10.1101/2021.08.29.21262798, https://www.medrxiv.org/content/10.1101/2021.08. 29.21262798v1). If the cycle of re-inoculation breaks or is altered the outcome may vary.
Know more:
Peter McCullough speaks at the 78th Annual Meeting of the Association of American Physicians and Surgeons on October 2, 2021. https://rumble.com/vnc5yk-dr.-peter-mccullough-therapeutic-nihilism-and-untested-novel-therapies-aaps.html
Thank you!!
ReplyDeletefatty liver treatment chennai
Liver doctor in chennai
Thank you!!
ReplyDeleteUterus Transplant
Womb transplantation